newsfilter
← Latest News
GlobeNewswire·

Genenta Science and AGC Biologics Enter Development and Manufacturing Service Agreement

MILAN, N.Y., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ:GNTA), a clinical-stage biotechnology company engaged in the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, has